AmeriFlex Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

AmeriFlex Group’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.2K	Hold	291	–	–	0.01%	563
2025 Q4	$24.7K	Sell	291 -291	-50%	-$23.2K	0.01%	555
2025 Q3	$42.2K	Buy	582 +291	+100%	+$20.1K	0.02%	484
2025 Q2	$19.2K	Hold	291	–	–	0.01%	580
2025 Q1	$20.5K	Hold	291	–	–	0.01%	685
2024 Q4	$20.2K	Buy	+291	New	+$20K	0.01%	621

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

MSCM

McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

AmeriFlex Group's IHE Position: Q1 2026 in Review

AmeriFlex Group held its iShares US Pharmaceuticals ETF (IHE) position steady in Q1 2026 at 291 shares worth $25.2K. The position accounts for 0.01% of the portfolio, ranked #563.

AmeriFlex Group first reported a position in IHE in Q4 2024 and has held it in 6 quarters since. The position peaked at $42.2K in Q3 2025. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

AmeriFlex Group held 291 shares of iShares US Pharmaceuticals ETF worth $25.2K as of Q1 2026.
AmeriFlex Group left its iShares US Pharmaceuticals ETF share count unchanged in Q1 2026.
iShares US Pharmaceuticals ETF made up 0.01% of AmeriFlex Group's portfolio in Q1 2026, its #563 holding.
AmeriFlex Group first reported a position in iShares US Pharmaceuticals ETF in Q4 2024 and has held it in 6 quarters since.
AmeriFlex Group's iShares US Pharmaceuticals ETF position peaked at $42.2K in Q3 2025.
194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on AmeriFlex Group's 13F filing for Q1 2026, filed 15 May 2026.